Toward Effective Identification of FASD: Considerations for Enhancing Evidence-Based Screening Within An Implementation Science Framework

Main Article Content

Kaitlyn McLachlan
Bianka Dunleavy
Melissa Grubb


The need to improve identification and understanding of individuals who have fetal alcohol spectrum disorder (FASD), including their strengths and challenges, is being increasingly recognized. Identification of FASD via screening is an important system-level intervention that may serve to improve early and accurate recognition of individuals who may have FASD, facilitate the provision of appropriately tailored support and interventions, and in doing so, foster healthy and positive outcomes for individuals and families. Effective and ethical implementation of FASD screening practices requires consideration of several factors for success, ensuring that resulting benefits outweigh potential harms. Using an implementation science framework, this topical review aims to provide an overview of these key considerations in order to guide further research and support practice and decision-making for service providers, organizations, and policy makers in the implementation of FASD identification and screening practices. These include prioritizing partnerships with stakeholders; taking a person-centered and ethical approach to FASD identification and screening; applying rigorous methodological research approaches to screening tool development, validation, and evaluation; increasing broader FASD awareness and response capacity at the system level; and advocating for continued policy reform and resources to enhance effective community-based support and
interventions following identification.


Download data is not yet available.

Article Details

How to Cite
McLachlan, K., Dunleavy, B., & Grubb, M. (2022). Toward Effective Identification of FASD: : Considerations for Enhancing Evidence-Based Screening Within An Implementation Science Framework. Journal of Fetal Alcohol Spectrum Disorder, 4(SP1), e60-e69.
Author Biographies

Kaitlyn McLachlan, Department of Psychology, University of Guelph, Guelph, ON, Canada

Department of Psychology, University of Guelph, Guelph, ON, Canada

Bianka Dunleavy, Department of Psychology, University of Guelph, Guelph, ON, Canada

Department of Psychology, University of Guelph, Guelph, ON, Canada

Melissa Grubb, Department of Psychology, University of Guelph, Guelph, ON, Canada

Department of Psychology, University of Guelph, Guelph, ON, Canada


1. Cook JL, Green CR, Lilley CM, et al. Fetal alcohol spectrum disorder: A guideline for diagnosis across the lifespan. Can Med Assoc J (CMAJ). 2016;188(3):191–7.
2. Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated clinical guidelines for diagnosing fetal alcohol spectrum disorders. Pediatrics. 2016;138(2):1–18.
3. Mattson SN, Bernes GA, Doyle LR. Fetal alcohol spectrum disorders: A review of the neurobehavioral deficits associated with prenatal alcohol exposure. Alcohol Clin Exp Res. 2019;43(6):1046–62.
4. Flannigan K, Wraith A, Ritter C, et al. Balancing the story of fetal alcohol spectrum disorder: A narrative review of the literature on strengths. Alcohol Clin Exp Res. 2021;45:2448–64.
5. Greenmyer JR, Popova S, Klug MG, Burd L. Fetal alcohol spectrum disorder: A systematic review of the cost of and savings from prevention in the United States and Canada. Addiction. 2020;115(3):409–17.
6. May PA, Chambers CD, Kalberg WO, et al. Prevalence of fetal alcohol spectrum disorders in 4 US communities. J Am Med Assoc (JAMA). 2018;319(5):474.
7. May PA, Hasken JM, Bozeman R, et al. Fetal alcohol spectrum disorders in a rocky mountain region city: Child characteristics, maternal risk traits, and prevalence. Alcohol Clin Exp Res. 2020;44(4):900–18.
8. Popova S, Lange S, Burd L, et al. Cost of fetal alcohol spectrum disorder diagnosis in Canada. PloS One. 2013;8(4):e60434.
9. Popova S, Lange S, Poznyak V, et al. Population-based prevalence of fetal alcohol spectrum disorder in Canada. BMC Public Health. 2019;19(1):845.
10. Popova S, Dozet D, Burd L. Fetal alcohol spectrum disorder: Can we change the future? Alcohol Clin Exp Res. 2020;44(4):815–9.
11. Streissguth A, Bookstein F, Barr H, et al. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004;25(4):228–38.
12. Pei, J, Poth, C, Tremblay, M. Walker, M. An integrative systems approach to enhancing service delivery for individuals with complex needs. Curr Dev Disord Rep. 2022;8(2): 57–68.
13. Bell E, Andrew G, di Pietro N, et al. It’s a shame! Stigma against fetal alcohol spectrum disorder: Examining the ethical implications for public health practices and policies. Public Health Ethics. 2016;9(1):65–77.
14. Chasnoff I, Wells A, King L. Misdiagnosis and missed diagnoses in foster and adopted children with prenatal alcohol exposure. Pediatrics. 2015;135(2):264–70.
15. Clarren SK, Lutke J, Sherbuck M. The Canadian guidelines and the interdisciplinary clinical capacity of Canada to diagnose fetal alcohol spectrum disorder. J Dev Behav Pediatr. 2011;18:e494–9.
16. Corrigan PW, Lara JL, Shah BB, et al. The public stigma of birth mothers of children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2017;41(6):1166–73.
17. Payne J, Elliott E, D’Antoine H, et al. Health professionals’ knowledge, practice and opinions about fetal alcohol syndrome and alcohol consumption in pregnancy. Aust N Z J Public Health 2005;29(6):558–64.
18. Wedding D, Kohout J, Mengel MB, et al. Psychologists’ knowledge and attitudes about fetal alcohol syndrome, fetal alcohol spectrum disorders, and alcohol use during pregnancy. Prof Psychol Res Pr. 2007;38(2):208–13.
19. McLachlan K, Flannigan K, Temple V, et al. Difficulties in daily living experienced by adolescents, transition-aged youth, and adults with fetal alcohol spectrum disorder. Alcohol Clin Exp Res. 2020;44(8):1609–24.
20. Streissguth A, Barr HM, Kogan J, Bookstein FL. Understanding the occurrence of secondary disabilities in clients with fetal alcohol syndrome (FAS) and fetal alcohol effects (FAE). Seattle, WA: University of Washington; Centers for Disease Control and Prevention;1996. 72 p. Available from:
21. Petrenko CLM, Tahir N, Mahoney EC, Chin, NP. Prevention of secondary conditions in fetal alcohol spectrum disorders: Identification of systems-level barriers. Matern Child Health J. 2014;18(6):1496–505.
22. Autti-Rämö I. Ethical challenges when screening for and diagnosing FASD in adults. In: Nelson M, Trusller M, editors. Fetal alcohol spectrum disorders in adults: Ethical and legal perspectives: An overview on FASD for professionals. 1st ed. New York, NY: Springer; 2016. pp. 85–97.
23. Berrigan P, Andrew G, Reynolds J, Zwicker J. The cost-effectiveness of screening tools used in the diagnosis of fetal alcohol spectrum disorder: A modelled analysis. BMC Public Health. 2019;19(1).
24. Goh Y, Chudley AE, Clarren SK, et al. Development of Canadian screening tools for fetal alcohol spectrum disorder. Can J Clin Pharmacol. 2008;15(2):344–66.
25. Grubb M, Golden A, Withers A, et al. Screening approaches for identifying fetal alcohol spectrum disorder in children, adolescents, and adults: A systematic review. Alcohol Clin Exp Res. 2021;45(8):1527–47.
26. Pedruzzi RA, Hamilton O, Hodgson HHA, et al. Navigating complexity to support justice-involved youth with FASD and other neurodevelopmental disbailities: Needs and challenges of a regional workforce. Health Justice. 2021;9(1):1–12.
27. Lim YH, Watkins RE, Jones H, Kippin NR, Finlay-Jones, A. Fetal alcohol spectrum disorders screening tools: A systematic review. Res Dev Disabil. 2022;122:104168.
28. Palermo, TM. New guidelines for publishing review articles in JPP: Systematic reviews and topical reviews. J Pediatr Psychol. 2013;38(1):5–9.
29. Fixsen D, Naoom S, Blase K, et al. Implementation research: A synthesis of the literature. Tamps, FL: National Implementation Research Network; 2005. Available from:
30. Bright Futures Steering Committee. Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening. Pediatrics. 2006;118(1):405–20.
31. Coles CD, Gailey AR, Mulle JG, et al. A comparison among 5 methods for the clinical diagnosis of fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2016;40(5):1000–9.
32. Vepsä KH. Is it FASD? And does it matter? Swedish perspectives on diagnosing fetal alcohol spectrum disorders. Drug Edu Prev Policy. 2020;28(6):1–11.
33. Dozet D, Burd L, Popova S. Screening for alcohol use in pregnancy: A review of current practices and perspectives. Int J Ment Health Addict. 2021:1–20.
34. Glascoe FP. Screening for developmental and behavioral problems. Ment Retard Dev Disabil Res Rev (Online). 2005;11(3):173–9.
35. Marlow M, Servili C, Tomlinson M. A review of screening tools for the identification of autism spectrum disorders and developmental delay in infants and young children: Recommendations for use in low- and middle-income countries. Autism Res. 2019;12(2):176–99.
36. Klug MG, O’Connell AM, Palme A, et al. A validation study of the alcohol-related neurodevelopmental disorders behavioral checklist. Alcohol Clin Exp Res. 2021;45(4):765–72.
37. McLachlan K, Amlung M, Vedelago L, Chaimowitz G. Screening for fetal alcohol spectrum disorder in forensic mental health settings. J Forens Psychiatry Psychol. 2020;31(5):643–66.
38. Blase KA, van Dyke M, Fixsen DL, Bailey FW. Implementation science. In: Kelly B, Perkins DF, editors. Handbook of implementation science for psychology in education. Cambridge, UK: Cambridge University Press; 2012. pp. 13–34.
39. Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):1–15.
40. Petrenko C, Alto M. Interventions in fetal alcohol spectrum disorders: An international perspective. Eur J Med Genet. 2017;60(1):79–91.
41. Dobrow M, Hagens V, Chafe R, et al. Consolidated principles for screening based on a systematic review and consensus process. Can Med Assoc J (CMAJ). 2018;190(14):E422–9.
42. McNeely J, Kumar P, Rieckmann T, et al. Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: A qualitative study of patients, providers, and staff. Addict Sci Clin Pract. 2018;13(1):8.
43. Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
44. Braithwaite J. Plan, do, study, act (PDSA). In Implementation science Routledge. Oxfordshire, UK: Taylor & Francis; 2022. pp. 83–84.
45. Helgesson G, Bertilsson G, Domeij H, et al. (2018). Ethical aspects of diagnosis and interventions for children with fetal alcohol spectrum disorder (FASD) and their families. BMC Med Ethics. 2018;19(1):1–7.
46. Zizzo N, di Pietro N, Green C, et al. Comments and reflections on ethics in screening for biomarkers of prenatal alcohol exposure. Alcohol Clin Exp Res. 2013;37(9):1451–5.
47. Grant TM, Novick Brown N, Graham JC, et al. Screening in treatment programs for fetal alcohol spectrum disorders that could affect therapeutic progress. Int J Alcohol Drug Res. 2013;2(3):37.
48. Rutman D. Becoming FASD informed: Strengthening practice and programs working with women with FASD. Subst Abuse. 2016;10(Suppl 1):13.
49. Jirikowic T, Olson HC, Kartin D. Sensory processing, school performance, and adaptive behavior of young school-age children with fetal alcohol spectrum disorders. Phys Occup Ther Pediatr. 2008;28(2):117–36.
50. McLachlan K, Mullally K, Ritter C, et al. Fetal alcohol spectrum disorder and neurodevelopmental disorders: An international practice survey of forensic mental health clinicians. Int J Forensic Ment Health. 2021;20(2).
51. Pei J, Kapasi A, Kennedy K, Joly V. Towards healthy outcomes for individuals with fetal alcohol spectrum disorder. Vancouver, BC, Canada: Canada FASD Research Network in collaboration with the University of Alberta; 2019. 56 p. Available from:
52. Goh PK, Doyle LR, Glass L, et al. A decision tree to identify children affected by prenatal alcohol exposure. J Pediatr. 2016;177:121.
53. May PA, Baete A, Russo J, et al. Prevalence and characteristics of fetal alcohol spectrum disorders. Pediatrics. 2014;134(5):855–66.
54. Pei J, Reid-Westoby C, Siddiqua A, et al. Teacher-reported prevalence of FASD in kindergarten in Canada: Association with child development and problems at home. J Autism Dev Disord. 2020;51(2):433–43.
55. Maxim LD, Niebo R, Utell MJ. Screening tests: A review with examples. Inhal Toxicol. 2014;26(13):811.
56. Pei J, Tremblay M, Poth C, et al. Best practices for serving individuals with complex needs: Guide and evaluation toolkit. Report Prepared by the Alberta Clinical and Communit-Based Evaluation and Research Team (ACCERT). Edmonton, AB, Canada: PolicyWise for Children and Families in collaboration with the University of Alberta; 2018. 179 p. Available from:
57. Substance Abuse and Mental Health Services Administration. Addressing fetal alcohol spectrum disorders (FASD). Treatment improvement protocol (TIP) series. Rockville, MD: US Department of Health and Human Services; 2014. 226 p. Available from:
58. Burd L, Martsolf JT, Juelson T. Fetal alcohol spectrum disorder in the corrections system: Potential screening strategies. FAS@JUS (CD-Rom) 2004;2:e1. Available from:
59. Patel M, Agnihotri S, Hawkins C, et al. Identifying fetal alcohol spectrum disorder and psychiatric comorbidity for children and youth in care: A community approach to diagnosis and treatment. Child Youth Serv Rev. 2019;108:104606.
60. Kapasi A, Makela M, Flannigan K, et al. Understanding employment success in adults with fetal alcohol spectrum disorder. J. Vocat Rehabil. 2019;51(3):377–93.
61. British Columbia’s Representative for Children and Youth. Excluded: Increasing Understanding, Support and Inclusion for Children with FASD and their families. Victoria, BC: The Representative for Children and Youth; 2021. 148 p. Available from:
62. Yousefi N, Chaufan C. Think before you drink: Challenging narratives on foetal alcohol spectrum disorder and indigeneity in Canada. Health. 2021;1–21.
63. Tait C. Fetal alcohol syndrome among aboriginal people in Canada: Review and analysis of the intergenerational links to residential schools. Ottawa, Canada: Aboriginal Healing Foundation; 2003. 364 p. Available from:
64. Dej E. What once was sick is now bad: The shift from victim to deviant identity for those diagnosed with fetal alcohol spectrum disorder. Can J Sociol. 2011;36(2):137–60.
65. Roozen S, Stutterheim SE, Bos AER, et al. Understanding the social stigma of fetal alcohol spectrum disorders: From theory to interventions. Found Sci. 2020;1–19.
66. Gelb K, Rutman D. Substance using women with FASD and FASD prevention: A literature review on promising approaches in substance use treatment and care for women with FASD. Victoria, BC, Canada: Research Initiatives for Social Change Unit, University of Victoria; 2011. 48 p. Available from:
67. McLachlan K, Wyper K, Pooley A. (2013). Promising practices in substance abuse treatment for justice involved youth with an FASD. Alberta, Canada: The Asante Centre, University of Alberta; 2013. 7 p. Available from:
68. Brascoupé S, Waters C. Cultural safety: Exploring the applicability of the concept of cultural safety to aboriginal health and community wellness. J Aborig Health. 2009;5(2):6–41.
69. Broyles LM, Rodriguez KL, Kraemer KL, et al. A qualitative study of anticipated barriers and facilitators to the implementation of nurse-delivered alcohol screening, brief intervention, and referral to treatment for hospitalized patients in a Veterans Affairs Medical Center. Addict Sci Clin Pract. 2012;7(1):1–20.
70. Gahagan S, Sharpe T, Brimacombe M, et al. Pediatricians’ knowledge, training, and experience in the care of children with fetal alcohol syndrome. Pediatrics. 2006;118(3): e657–e668.
71. McLachlan K. Fetal alcohol spectrum disorder in Yukon corrections: Estimating the prevalence of FASD, mental health, and substance use problems in the justice system. Whitehorse, Yuko, Canada: Department of Justice Yukon; 2017. 79 p. Available from:
72. Mukherjee R, Wray E, Curfs L, Hollins S. Knowledge and opinions of professional groups concerning FASD in the UK. Adopt Foster. 2015;39(3):212–24.
73. Olson H, Sparrow J. A shift in perspective on secondary disabilities in fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2021;45(5):916–21.